Khat chewing is a risk factor for acute myocardial infarction: A case-control study

British Journal of Clinical Pharmacology

Volumn 59, Issue 5, 2005, Pages 574-581

  Al Motarreb, A ^a   Briancon, S ^b   Al Jaber, N ^a   Al Adhi, B ^a   Al Jailani, F ^a   Salek, M Sam ^c   Broadley, K J ^c  

^a Al Thawrah Teaching Hospital   (Yemen)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Case control study; Khat; Myocardial infarction; Smoking

Indexed keywords

CATHA EDULIS EXTRACT;

ACUTE HEART INFARCTION; ADULT; AGED; ALERTNESS; ARTICLE; BLOOD PRESSURE; CASE CONTROL STUDY; CATHA EDULIS; CONTROLLED STUDY; CORONARY RISK; DRUG EFFECT; FEEDING BEHAVIOR; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLANT LEAF; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT;

ADULT; AGED; CATHA; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; RISK FACTORS;

EID: 18244395303     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02358.x     Document Type: Article

References (22)

1. Kalix P. Cathinone a natural amphetamine. Pharmacol Toxicol 1992; 70: 77-86.
2. Al-Motarreb A, Baker K, Broadley KJ. Khat: Pharmacological and medical aspects and its social use in Yemen. Phytother Res 2002; 16: 403-13.
3. Drake PH. Khat-chewing in the near east. Lancet 1988; 5: 532-3.
4. Griffiths P. Qat use in London. A study of qat use among a sample of Somalis living in London. Home Office Drug Prevention Initiative. London: Home Office 1998.
5. Kalix P, Braenden O. Pharmacological aspects of the chewing of khat leaves. Pharmacol Rev 1985; 37: 149-64.
6. Brenneisen R, Fisch HU, Koelbing U, Geisshusler S, Kalix P. Amphetamine-like effects in humans of the khat alkaloid cathinone. Br J Clin Pharmacol 1990; 30: 825-8.
7. Pehek EA, Schechter MD, Yamamoto BK. Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo. Neuropharmacology 1990; 29: 1171-6.
8. Kalix P. The pharmacology of khat. Gen Pharmacol 1984; 15: 179-87.
9. Kalix P. Effects of the alkaloid cathinone on the release of radioactivity from rabbit atria prelabelled with 3H-norepinehrine. Life Sci 1983; 32: 801-7.
10. Hassan NA, Gunaid AA, Abdo-Rabbo AA, et al. The effect of khat chewing on blood pressure and heart rate in healthy volunteers. Trop Doct 2000; 30: 107-8.
11. Kohli J, Goldberg L. Cardiovascular effect of (-)-cathinone in the anaesthetized dog: comparison with (+)-amphetamine. J Pharm Pharmacol 1982; 34: 338-40.
12. Gugelmann R, Von Allmen M, Breinneisen R, Portzig H. Quantitative differences in the pharmacological effect of (+) and (-)-cathinone. Experientia 1985; 41: 1568-71.
13. Widler P, Mathys K, Brenneisen R, Kalix P, Fisch H-U. Pharmacodynamics and pharmacokinetics of khat: a controlled study. Clin Pharmacol Ther 1994; 55: 556-62.
14. Al-Motarreb A, Al-Kebsi M, Al-Adhi B, Broadley KJ. Khat chewing and acute myocardial infarction. Heart 2002; 87: 279-80.
15. Hoffman BB, Lefkowitz RJ. Catecholamines and sympathomimetic drugs. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th edn, ed. Gilman AG, Rall TW, Nies AS, Taylor P. New York. Pergamon Press, 1990.
16. Gaziano JM, Hennekens CH, Saterfield S, et al. Clinical utility of lipid and lipoprotein levels during hospitalization for acute myocardial infarction. Vase Med 1999; 4: 227-31.
17. Gehani AA, Al-Mulla AW, Chaikhouni A, et al. Myocardial infarction with normal coronary angiography compared with severe coronary artery disease without myocardial infarction: the crucial role of smoking. J Cardiovasc Risk 2001; 8: 1-8.
18. Ragland AS, Ismail Y, Arsura EL. Myocardial infarction after amphetamine use. Am Heart J 1993; 125: 247-9.
19. Packe GE, Garton MJ, Jennings K. Acute myocardial infarction caused by intravenous amphetamine abuse. Br Heart J 1990; 64: 23-4.
20. Bashour TT. Acute myocardial infarction resulting from amphetamine abuse: a spasm-thrombus interplay? Am Heart J 1994; 128: 1237-9.
21. Henry JA, Jeffries KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy'). Lancet 1992; 340: 384-6.
22. Gledhill JA, Moore DF, Bell D, Henry JA. Subarachnoid hemorrhage associated with MDMA abuse. J Neurol Neurosurg Psychiatry 1993; 56: 1036-7.